US5384134A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Anti-inflammatory formulations for inflammatory diseases
Assignee: Alcide Corp
•
Filing: 1993-09-01
•
Granted: 1995-01-24
•
Expires: 2013-09-01
Abstract
Abstract There is disclosed a method for treating dermatologic diseases caused by microbial overgrowth or inflammation, such as psoriasis, fungal infections, eczema, dandruff, acne, genital herpes lesions, and leg ulcers. There is further disclosed an antiviral lubricating composition that is effective in preventing the transmission of the HIV virus and other sexually transmitted diseases. There is also disclosed systemic anti-inflammatory compositions and formulations and a method for reducing tissue inflammation in tissues such as the bowel, muscle, bone, tendon and joints (e.g., arthritis).
Inventors
- 👤 Robert D. Kross
- 👤 Elliott J. Siff
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 09:32
CPC Classifications
A; A61; A61K; A61K33/00; A61K33/40; A61P; A61P17/00; A61P29/00; A61P31/00; A61P31/12; A61P31/20; A61P31/22
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
99 words
A method for reducing tissue inflammation comprising topically applying a pharmaceutically effective amount of an anti-inflammatory composition comprising a mixture of a first solution, cream, or gel consisting essentially of a chlorine dioxide liberating compound and a second solution, cream, or gel consisting essentially of a protic acid, wherein the chlorine dioxide liberating compound comprises a metal chlorite, and wherein the chlorite ion concentration in the form of chlorous acid is no more than about 15% by weight of the total amount of chlorite ion concentration in the composition and wherein the gel or cream optionally contains a thickener.
Claim 2
Independent Claim
99 words
A method for reducing tissue inflammation comprising topically applying a pharmaceutically effective amount of an anti-inflammatory composition comprising a mixture of a first solution, cream, or gel consisting essentially of a chlorine dioxide liberating compound and a second solution, cream, or gel consisting essentially of a protic acid, wherein the chlorine dioxide liberating compound comprises a metal chlorite, and wherein the chlorite ion concentration in the form of chlorous acid is no more than about 15% by weight of the total amount of chlorite ion concentration in the composition and wherein the gel or cream optionally contains a thickener.
Claim 3
Dependent Claim
19 words
The method of claim 1 wherein the pK of the protic acid is from about 2.8 to about 4.2.
Claim 4
Dependent Claim
24 words
The method of claim 1 wherein the first solution, cream, or gel is a gel and contains a polysulfonic acid salt as a thickener.
Claim 5
Independent Claim
93 words
A method for treating inflammatory disorders comprising locally administering a pharmaceutically effective amount of a composition comprising a first solution or gel consisting essentially of a chlorine dioxide liberating compound, and a second solution or gel consisting essentially of a protic acid, wherein the chlorine dioxide liberating compound comprises a metal chlorite, and wherein the chlorite ion concentration in the form of chlorous acid is no more than about 15% by weight of the total amount of chlorite ion concentration in the composition and wherein the gel or cream optionally contains a thickener.
Claim 6
Independent Claim
93 words
A method for treating inflammatory disorders comprising locally administering a pharmaceutically effective amount of a composition comprising a first solution or gel consisting essentially of a chlorine dioxide liberating compound, and a second solution or gel consisting essentially of a protic acid, wherein the chlorine dioxide liberating compound comprises a metal chlorite, and wherein the chlorite ion concentration in the form of chlorous acid is no more than about 15% by weight of the total amount of chlorite ion concentration in the composition and wherein the gel or cream optionally contains a thickener.
Claim 7
Dependent Claim
19 words
The method of claim 4 wherein the pK of the protic acid is from about 2.8 to about 4.2.
Claim 8
Dependent Claim
14 words
The method of claim 5 wherein the chlorine dioxide liberating compound is sodium chlorite.
Claim 9
Dependent Claim
25 words
The method of claim 4 wherein the inflammatory disorder is selected from the group consisting of arthritis, lupus, bowel inflammation, tendon inflammation and muscle inflammation.
References Cited (Backward Citations)
US4084747A
Cited
US4330531A
Cited
US4540567A
Cited
US4381296A
Cited
US5185161A
Cited
US4690772A
Cited
WO1988001507A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-01-23 | 1998-07-25 | 1999-01-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-01-23 | 2002-07-25 | 2003-01-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-01-23 | 2006-07-25 | 2007-01-24 | $7700.00 | Window Closed / Lapsed |